SLC35A2 expression is associated with HER2 expression in breast cancer
Abstract The role of SLC35A2 in breast cancer remains poorly understood, with limited available information on its significance. This study aimed to investigate the expression of SLC35A2 and clinicopathological variables in breast cancer patients. Immunohistochemical analysis of SLC35A2 protein was...
Main Authors: | Yiran Wang, Xiaobo Peng, Meihong Wu, Bin Wang, Tianran Chen, Xianbao Zhan |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer
2024-04-01
|
Series: | Discover Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1007/s12672-024-00978-2 |
Similar Items
-
Clinical significance and expression of SLC35F6 in bladder urothelial carcinoma
by: Jinling Zhang, et al.
Published: (2024-11-01) -
Prognostic Role of Androgen Receptor Expression in HER2+ Breast Carcinoma Subtypes
by: Sandra Orrù, et al.
Published: (2022-01-01) -
Correlation of the HER-2 protein expression and other clinicopathological features of ductal infiltrative breast cancer
by: Svjetlana Radović, et al.
Published: (2005-02-01) -
Novel Insights into the Prognosis and Immunological Value of the SLC35A (Solute Carrier 35A) Family Genes in Human Breast Cancer
by: Hoang Dang Khoa Ta, et al.
Published: (2021-11-01) -
Study on clinicopathological features and prognosis of HER2 low expression breast cancer
by: RUAN Miao, DA Qian, XU Haimin, DONG Lei, FEI Xiaochun
Published: (2024-10-01)